The mutation frequency of pS189 shuttle vector plasmids is higher in human oral keratinocytes (NHOK) immortalized with cloned human papillomavirus-16 (HPV-16) genome than in primary normal NHOK (NHOK). To determine whether oncoproteins E6 and E7 of HPV-16 are responsible for the higher mutation frequency of the plasmids, we measured the mutation frequency in NHOK and in NHOK expressing the HPV-16 oncogenes (E6, E7, or E6 plus E7). We also measured the mutation frequency in NHOK expressing the E6 or E7 proteins of the non-oncogenic HPV-6b. The mutation frequency, either background or N-methyl-N'-nitro-Nnitrosoguanidine (MNNG)-induced, in NHOK expressing the HPV-16 oncoproteins (E6, E7, or E6 plus E7) was signi®cantly higher than in NHOK. The HPV-16 oncogenes did not alter the nature of the MNNG-induced mutations (G : C?A : T), but increased the frequency of deletions and insertions with or without MNNG. The background or MNNG-induced mutation frequency in NHOK expressing the HPV-6b E6 or E7 proteins was the same as in NHOK. NHOK and NHOK expressing HPV6b-E6 or E7 were able to arrest the cell cycle and enhance cellular p53, p21 WAF1/CIP1 , and Gadd45 levels when exposed to MNNG, whereas NHOK expressing the HPV-16 E6 oncogene did not demonstrate. NHOK expressing HPV-16 E7 were able to enhance cellular p53, p21 WAF1/CIP1 , and Gadd45 levels, but failed to arrest cell cycle progression when exposed to MNNG. These data indicate that HPV-16 E6 and E7 oncogenes are mutagenic in human oral keratinocytes and enhance the mutagenic eect of MNNG. However, the E6 and E7 proteins of the`low risk' HPV-6b did not demonstrate such an ability.
Introduction
Transfection of normal human oral keratinocytes (NHOK) with the cloned genomes of`high risk' HPV-16 or HPV-18 results in immortalization of the cells (Park et al., 1991; Shin et al., 1994) . The HPVimmortalized human oral keratinocytes (NHOK) contain integrated entire HPV genomes and stably express the viral oncogenes E6 and E7. Treatment with chemical carcinogens further transforms the HPVimmortalized cells into tumorigenic cells but does not transform normal (NHOK) Park et al., 1995) . The tumorigenic cells proliferated better in an ordinary culture medium containing a physiological level of calcium (1.5 mM), and transcribed substantially higher amounts of HPV E6/E7, epidermal growth factor receptors, and c-myc genes when compared to their immortalized counterpart.
Genotoxic agents are known to enhance the level of intranuclear wt p53 protein (Maltzman and Czyzyk, 1984; Kastan et al., 1991; Baek et al., 1994; Gujuluva et al., 1994) . This enhanced intranuclear wt p53 protein level in turn induces the upregulation of WAF1/CIP1 and gadd45 gene expression. The p21 WAF1/CIP and Gadd45 proteins are involved in the DNA repair process and the arrest of cell cycle progression (Kastan et al., 1991; Gujuluva et al., 1994; Zhan et al., 1993) . p53 may also be directly involved in transcriptioncoupled DNA repair (Wang et al., , 1995 by being associated with one of DNA helicases, ERCC3/XPB, a subunit of TFIIH (Wang et al., 1989) . p53 is associated with other DNA repair proteins such as XPB in vivo and XPD and CSB in vitro, and directly modulates the function of XPB and XPD (Wang et al., 1995) .
Cells expressing`high risk' HPV E6 protein contain extremely low or negligible amounts of p53 compared to normal cells (Werness et al., 1990; Schener et al., 1991) , and do not increase the level of p53, p21 WAF1/CIP1 , and Gadd45 proteins when challenged by genotoxic agents (Kessis et al., 1993; Baek et al., 1994; Gujuluva et al., 1994) . Recently, Havre et al. (1995) demonstrated that p53 inactivation by HPV-16 E6 resulted in increased spontaneous mutation frequency of hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in a human colon carcinoma cell line. Nevertheless, the eect of`high risk' HPV oncogenes E6 and E7 on spontaneous or genotoxic agent-induced mutation frequency of human gene(s) or exogenous DNA has never been studied in normal human keratinocytes. Inasmuch as the phenotypes and genotypes of cancer cells are notably dierent from those of normal cells, the mutagenicity of HPV oncogenes in cancer cells could be dierent from those in normal cells. Thus it is necessary to investigate the mutagenicity of HPV oncogenes E6 and E7 in normal human oral keratinocytes, one of the target cells of`high risk' HPV.
The pS189 shuttle vector plasmid which can replicate in both eukaryotes and prokaryotes has been successfully used to investigate the mutagenicity of various chemicals in mammalian cells, including lymphoblasts (Seidman et al., 1987) , cells from xeroderma complementation groups (Bredberg et al., 1986) , and green monkey kidney cells (Shillitoe et al., 1993) . It contains a 150 base pair suppressor tRNA, sup F, which serves as a target for mutagens and whose activity can be monitored in the E. coli strain MBM7070 that carries a lacZ amber mutation. Using this system we have previously reported that both background and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced mutation frequencies of the shuttle vector plasmid were notably higher in HPV-16 or -18 immortlized cells than in normal cells (Shin et al., 1996) . These results indicated that expression of HPV-16 or 18 DNA enhances the mutation frequency either due to increased mutagenesis, decreased DNA repair, or both. This increased DNA instability could be responsible for the greater susceptibility to chemical carcinogens in HPV-immortalized keratinocytes.
As a ®rst step to comprehend the underlying mechanism of this increased mutation frequency in HPV-immortalized cells, we investigated whether the viral oncogenes E6 and E7 are responsible for this phenomenon without the help of other viral genes or other cellular alterations and whether they alter the nature of the mutations, G : C to A : T, caused by MNNG. We also compared the expression of p53, p21 WAF1/CIP and Gadd45 proteins and progression of the cell cycle in NHOK and in NHOK infected with retrovirus capable of expressing HPV-16 oncoproteins E6 and/or E7 with or without exposure to MNNG. MNNG was found to arrest cell cycle progression and enhance the levels of cellular p53, p21
, and Gadd45 proteins in NHOK but not in NHOK expressing the viral onogene E6 or E6 plus E7. NHOK expressing HPV-16 E7 were able to enhance cellular p53, p21
, and Gadd45 protein levels, but failed to arrest cell cycle progression when exposed to MNNG. The mutation frequency of the plasmids, both background and MNNG-induced, in NHOK expressing HPV-16 oncoproteins (E6, E7, or E6/E7) was signi®cantly higher than those in NHOK. Although the viral oncogenes did not alter the nature of mutations caused by MNNG, they increased the frequency of deletions and insertions with or without MNNG. These data indicate that HPV-16 E6 and E7 proteins demonstrate mutagenicity in human oral keratinocytes and interfere with the DNA repair process, possibly, in part, through the inactivation of p53 and pRB functions and alteration of p53-mediated functions.
Results
HPV-16 E6 oncogene prevents the increase in the level of cellular p53, p21 WAF1/CIP1 , and Gadd45 proteins which are induced in NHOK by MNNG exposure As shown in Figure 2 , HPV-16 oncogene E6, but not oncogene E7, prevented this increase. MNNG-exposure signi®cantly enhanced the p53 protein level in NHOK, NHOK/LXSN, and NHOK/16E7 cells, but did not in NHOK/16E6 and NHOK/16E6E7 cells. Also, HPV-16 oncogene E6, but not E7, prevented the increase of the p21 WAF1/CIP1 and Gadd45 proteins which were enhanced by MNNG-exposure in NHOK, NHOK-LXSN, and NHOK/16E7 cells. In contrast, the E6 gene of the non-oncogeneic HPV-6b did not aect the increase in p53 level. As in normal cells, the levels of p53, p21
, and Gadd45 proteins were notably enhanced by MNNG in NHOK/6bE6 and NHOK/6bE7 cells (Figure 3 ).
HPV-16 E6 or E7 oncogene abrogates the cell cycle arrest induced by MNNG in normal NHOK
All the tested replicating cells showed a cell cycle distribution of approximately 30% in G 1 /G 0 , 30% in S, and 40% in G 2 /M phases. At 10 h after a 2 h exposure to MNNG, cell cycle arrest was evident in NHOK and in control NHOK-LXSN cells. However, HPV-16 oncogenes E6 and E7 prevented this arrest (Figure 4) . , and Gadd45 from cells exposed or not exposed to MNNG. (7): Unexposed cells (+): MNNG exposed cells After MNNG-exposure cell cycle progression proceeded normally in NHOK/16E6, NHOK/16E7, and NHOK/16E6E7 cells. The eect of HPV-16 E7 oncogene is consistent with its known alteration of cellular functions which operate downstream of the p53 functions and aect cellular replication.
The E6 and E7 genes of HPV-6b did not abrogate the cell cycle arrest induced by MNNG ( Figure 5 ). The NHOK/6bE6 and NHOK/6bE7 cells underwent cell cylce arrest as did normal cells.
HPV-16 E6 and E7 oncogenes increase the background mutation frequency of pS189 shuttle vector plasmids
As shown in Table 1 , the background mutation frequencies of the pS189 shuttle vector plasmids in NHOK/16E6, NHOK/16E7, and NHOK/16E6E7 cells were 3.4, 2.3, and 3.5 fold higher, respectively, than the mutation frequency in NHOK and control NHOK-LXSN cells. In contrast, the E6 and E7 genes of the non-onocogeneic HPV-6b did not alter the mutation frequency of the plasmids. The apparent higher 1.6-fold mutation frequency in NHOK/6bE6 cells was not statistically dierent from that in control cells and the mutation frequency in HPV/6bE7 was similar to that in NHOK. These results indicate that the HPV-16E6 and E7 oncogenes introduce errors in the replication of exogenous DNA in human oral keratinocytes.
HPV-16 E6 and E7 oncogenes enhanced the mutation frequency of pS189 shuttle vector plasmids after exposure of host cells to MNNG. Exposure to MNNG enhances approximately three times the mutation frequency of the plasmids in all tested cells (Table 1) . However, whereas the MNNG-induced mutation frequency in cells not containing the viral oncogenes was threefold that in normal cells, in cells expressing HPV-16 oncogenes E6 and E7 the mutation frequency was tenfold higher than in normal cells. Unlike the oncogenes of the`high risk' HPV-16, the E6 and E7 genes of the`low risk' HPV-6b did not increase the MNNG-induced mutation frequency above that found in NHOK or NHOK/LXSN. It appears therefore that the HPV-16 oncogenes not only raise the background mutation frequency, but they also enhance the mutagenic eect of the carcinogen MNNG.
Mutation spectrum
The type of mutation in the supF sequence of the recovered mutant plasmids was classi®ed as either point mutation, deletion, or insertion after determination of the length and nucleotide sequence of the ampli®ed fragment. The mutant plasmids recovered from NHOK, NHOK/LXSN, NHOK/6bE6, and NHOK/6bE7 cells not exposed to MNNG showed the same pattern of mutations: point mutations, deletions, or insertions were
Figure 3 Western blot analysis of electrophoretically separated p53, p21
, and Gadd45 from NHOK, NHOK/6bE6, and NHOK/6bE7 cells exposed or not exposed to MNNG. Table 2) . Exposure of the host cells to MNNG resulted in a large increase in the number of mutant plasmids containing point mutations in the supF region. Among the mutant plasmids isolated from MNNG-exposed NHOK or NHOK/LXSN cells, 74% contained a point mutation. The same proportion (74%) of mutant plasmids containing point mutations was also found in NHOK/6bE6 and NHOK/6bE7 cells exposed to MNNG. This pattern of mutation was not altered by the expression of the HPV-16 E6 and E7 oncogenes: 79% of the mutant plasmids contained point mutations. Interestingly, there was, however, a doubling in the incidence of deletions and insertions in cells expressing the HPV-16 oncogenes regardless of whether or not they were exposed to MNNG. These errors in DNA replication suggest faulty DNA polymerization in the presence of the HPV-16 E6 and E7 products.
Nucleotide sequencing of the supF region of the point mutants isolated from cells exposed to MNNG revealed a variety of point mutations with 83% of them being G : C to A : T transition (Table 3) . This is consistent with the MNNG mutagenic speci®city reported in bacteria and mammalian cells (Burns et al., 1987 . Stary et al., 1992 Shin et al., 1996) . In cells expressing the HPV-16 oncogenes E6 and E7, the retention of the MNNG mutagenic speci®city as well as a tenfold enhancement of the MNNG mutagenic Not signi®cantly dierent from unexposed NHOK group. 7: unexposed; +: exposed to MNNG, 1.0 mg/ml. Cells transfected with pS189 were exposed to MNNG (1.0 mg/ml) for 2 h and incubated in fresh medium for 24 h. The pS189 plasmids were recovered and introduced into E. coli MBM7070. The mutagenesis assay was performed as described in Materials and methods. The mutation frequencies were analysed by Binomial comparison of two Poisson rates to determine their respective statistical signi®cance 7: unexposed; +: exposed to MNNG, 1.0 mg/ml. Cells (normal control, cells expressing`high risk' HPV-16 oncogene(s) or`low risk' HPV E6 or E7) were transfected with pS189, exposed to MNNG (1.0 mg/ml) for 2 h and incubated in fresh medium for 24 h. The pS189 plasmids were then recovered from the cells and introduced into E. coli MBM7070 to isolate mutant plasmids. The supF region of the mutant plasmids were PCR ampli®ed. The ampli®ed DNA fragments were electrophoresed to compare the size of the fragments. When the size of the ampli®ed fragment was greater or smaller than that of the wild-type, the mutation was classi®ed as insertion or deletion, respectively. The ampli®ed mutant fragments whose size was the same as that of the wild-type supF region, the mutation was classi®ed as point mutations as described in the text.
eect indicate that oncogenes E6 and E7 facilitate the mutagenic activity of MNNG or interfere with the DNA repair which occurs in normal cells.
Discussion
An early event in most cases of oral carcinogenesis appears to be p53 dysfunction, i.e. absence, decreased level, or mutations . Wild type p53 is involved in the control of cell cycle progression, DNA repair and DNA replication presumably via the expression of gadd45 and p21 WAF1/CIP1 proteins (ElDeiry et al., 1994; Zhan et al., 1994) . Increased levels of wild type p53 results in an over-expression of gadd45 and p21 WAF1/CIP1 which inhibits the activity of cyclinassociated kinases (El-Deiry et al., 1993; Harper et al., 1993) . The latter kinases normally phosphorylate the pRB which controls cell cycle transition from the G 1 to the S-phase. Both p21 WAF1/CIP1 and gadd45 have been reported to associate with the proliferating cell nuclear antigen (PCNA) that is required for DNA polymerization and presumably plays a major role in DNA repair as well as DNA replication (Ayyagari et al., 1995) . Addition of puri®ed Gadd45 protein has been reported to increase the nucleotide excision repair capacity in nuclear extracts of human cancer cells indicating a direct role in the DNA repair process (Smith et al., 1994) .
The exposure of NHOK to MNNG increased the levels of p53, p21 WAF1/CIP1 , and Gadd45 proteins and arrested the cell cycle. The HPV-16 E6 oncogene prevented this increase as well as the cell cycle arrest. Presumably this was caused by the rapid degradation of the p53 protein by the viral E6 oncoprotein (Schener et al., 1991) . Since the HPV-16 E7 oncoprotein does not interfere with the expression or the half-life of p53, this oncoprotein did not aect the increase of cellular p53, p21 WAF1/CIP1 , and Gadd45 proteins in cells exposed to MNNG. However, the HPV-16 E7 oncoprotein, like HPV-16 E6, prevented the arrest of cell cycle progression after exposure to MNNG. This was probably caused by the interaction of the E7 oncoprotein with the pRB and interference with its normal function, thereby abrogating the function of the p21 WAF1/CIP1 protein (Slebos et al., 1994) . However, although binding of HPV-16 E7 oncoprotein to pRB is necessary for cell growth arrest, several mutant HPV-16 E7 proteins, that can bind to pRB in vitro, fail to arrest cell cycle progression (Demers et al., 1996) , indicating that the binding of HPV-16 E7 to pRB is necessary, but not sucient for the bypassing negative growth signals.
We have used the pS189 shuttle vector plasmid which replicates in both eukaryotes and prokaryotes to investigate mutagenesis because it contains a 150 base pair target gene, supF, which has a low background mutation frequency in eukaryotic cells and can be conveniently assayed and quantitated (Seidman, 1989) . Moreover, the supF nucleotide sequence can be easily determined to identify the mutation spectrum (Shin et al., 1996) . The results demonstrated that the E6 and E7 oncogenes of HPV-16 are mutagenic. In NHOK expressing the HPV-16 oncogenes, the mutation frequency of the plasmids was threefold higher than in control NHOK. Unlike in cancer cells in which HPV-16 E7 did not show mutagenicity, the HPV-16 E7 oncogene was also mutagenic in NHOK, albeit somewhat less than E6, but there was no synergistic eect upon mutagenicity in the cells expressing both viral oncogenes. This might be expected since the HPV-16 E7 oncogene acts upon the pRB which controls cellular functions parallel but similar to p53. However, some mutant HPV-16 E7 proteins that were transformation de®cient were reported to bind to pRb in vitro (Demers et al., 1996) , indicating that the binding of HPV-16 E7 to pRB is necessary, but not sucient for the oncogenicity or possibly for the mutagenicity of HPV-16 E7. The E6 and E7 gene products of HPV-6b, a low risk HPV, were not mutagenic. The HPV-6b E6 protein binds only weakly to wild type p53 protein and may not alter its level nor its functions.
Exposure of normal cells to MNNG raised the mutation frequency 2.7-fold, entirely by increasing G : C to A : T point mutations. This increase in MNNG speci®c point mutations indicate that the mutations were not completely repaired under our experimental conditions. In cells, expressing HPV-16 oncoproteins the mutations frequency was increased tenfold by MNNG, also entirely attributable to an increase in G : C to A : T Table 3 Nature of point mutations in the supF sequence of the recovered pS189 shuttle vect plasmids
Number of plasmids with Host
Single point mutation Multiple Cells* G : C to A : T A : T to G : C G : C to C : C A : T to T : A A : T to C : G point mutations NHOK (7) NHOK (+) NHOK/LXSN (7) NHOK/LXSN (+) NHOK/16E6 (7) NHOK/16E6 (+) NHOK/16E7 (7) NHOK/16E7 (+) NHOK/16E6/E7 (7) NHOK/16E6/E7 (+) NHOK/6bE6 (7) NHOK/6bE6 (+) NHOK/6bE7 (7) NHOK/6bE7 (+)
*(+): exposed to MNNG, 1 mg/ml; (7): not exposed. The ampli®ed mutant fragments whose size was the same as that of the wild-type supF region were sequenced to identify the type of point mutation as described in the text point mutations. This enhanced mutagenicity in cells expressing the HPV-16 oncoproteins could result either from faulty DNA polymerization or from an impaired DNA repair mechanism, or from both phenomena. A defect in DNA repair is supported by the increased mutation frequency detectable in MNNG treated cells which is entirely due to the MNNG speci®c G : C to A : T point mutations. The doubling in the number of the deletions and insertions in cells expressing the HPV-16 oncogenes regardless of whether the cells are exposed to MNNG or not indicates a faulty DNA replication mechanism caused by the presence of the E6 and E7 oncogenes. Faulty DNA polymerization would impair the DNA repair mechanism. In support of this possibility it has been reported that the loss of induced nucleotide excision repair of u.v.-induced DNA damage is caused by high risk HPV-E6 oncogene in colon cancer cells (Smith et al., 1995) . Finally, we want to point out that the mutagenicity of HPV-16 E6 in NHOK is in accord with a report which indicated mutagenicity of the viral oncogene in RKO human colon carcinoma cell line (Havre et al., 1995) . However, unlike in the RKO cancer cells, the HPV-16 E7 oncogene also demonstrate the mutagenicity in NHOK. The HPV-6b E6 and E7 gene products did not aect the mutagenic eect of MNNG. The NHOK cells expressing these viral genes behaved like normal cells.
Materials and methods

Cells and cell culture
Primary NHOK were prepared and cultured in Keratinocyte Growth Medium (KBM) supplemented with the growth factor bullet kit (Clonetics, San Diego, CA) as previously described (Park et al., 1991 (Halber et al., 1991) . Retrovirus vector alone (LXSN) or retroviruses expressing these viral proteins were harvested from the PA317 cells: The viral titers were between 2610 5 ± 5610 5 colony forming units per milliliter. Forty to 60 per cent con¯uent NHOK were infected with retrovirus at a multiplicity of infection (m.o.i.) of one followed by selection with G418. The G418-resistant cells were pooled, named NHOK/LXSN (cells infected with empty retrovirus vector alone), NHOK/ 16E6 (cells expressing HPV-16 E6), NHOK/16E7 (cells expressing HPV-16 E7), NHOK/16E6E7 (cells expressing both HPV-16 E6 and E7), NHOK/6bE6 (cells expressing HPV-6b E6) and NHOK/6bE7 (cells expressing HPV-6b E7). The RNA from these cells was subjected to Northern blot analysis to ascertain the expression of the respective appropriate viral genes (Figure 1 ).
Western analysis
Eighty per cent con¯uent cells were cultured in the absence or presence of 1.0 mg/ml of MNNG for 2 h. At 10 h after MNNG exposure, the cells were lysed, denatured and processed for Western analysis to determine the cellular level of p53, p21 WAF1/CIP1 and Gadd45 proteins using the Western-Light kit (Tropic Inc, Bedford, MA) as previously described . Monoclonal antibodies to p53, Gadd45, and p21
were obtained from Oncogene Sciences (Cambridge, MA).
Northern analysis
Extraction of poly(A + ) RNA and Northern analysis were conducted. The poly(A + ) RNAs extracted from the NHOK, NHOK/LXSN, NHOK/16E6, NHOK/16E7, NHOK/16E6E7, NHOK/6bE6, and NHOK/6bE7 were subjected to Northern analysis using HPV-16 E6, HPV-16 E6, HPV-16E6/E7, HPV-6b E6, or HPV-6b E7 cDNA probes (from Dr D Galloway) to determine the expression of these genes from the cells (Figure 1) . The probes were labeled with [
32 P]-a-dCTP (ICN Biomedicals, Costa Mesa, CA) by multiprime labeling (Amersham Corp, Arlington Heights, IL). The speci®c radioactivity of the probes was always greater than 5610 8 c.p.m./mg of DNA.
Analysis of cell cycle
Cells at approximately 70 per cent con¯uences in 100 mm culture dishes were exposed to MNNG for 2 h, washed, incubated for ten additonal hours, labeled with 10 mM bromodeoxyuridine (BrdU, Sigma Chemical Co, St Louis, MO) for 2 h, and harvested by trypsinization. The cells were then ®xed in cold 70% ethanol for 1 h at 48C, pelleted, washed, resuspended in PBS containing 0.5 mg/ml RNaseA and incubated at 378C for 30 min. The RNAseAtreated cells were pelleted after adding 5 ml of phosphate buered saline (PBS), resuspended in 0.5 ml of deionized/ distilled water, and heated at 978C for 10 min. The samples were then chilled in ice for 15 min, centrifuged after adding 5 ml of PBS containing 0.5% Tween-20, and resuspended in PBT staining buer (PBS/0.5% Tween-20/5% fetal bovine serum). After adding 20 ml of anti-BrdU FITC conjugated antibody (Beckton-Dickenson, San Jose, CA) to each sample, they were incubated at room temperature for 30 min. Then 1.2 ml of PBT staining buer was added to each sample, centrifuged and the pellet resuspended in 0.5 ml of 10 mg/ml propidium iodide solution (Sigma Chemical Co, St Louis, MO) in PBS. The state of the cell cycle was then determined on a FACScan¯ow cytometer (Beckton-Dickenson, San Jose, CA) at 480 nm excitation. The 514 nm bandpass (BP5) ®lter and the 600 nm longpass (LP) ®lter were used for green fluorescence and red¯uorescence respectively.
Shuttle vector and bacteria
The shuttle vector pS189 plasmids and host E. coli strain MBM7070 obtained from Dr E Shillitoe (University of Texas Health Science, Houston, TX) were used. The plasmid DNA was prepared by the alkaline lysis method described elsewhere (Shin et al., 1996) .
Mutation frequency assay
Sixty to 70 per cent con¯uent cells were transiently transfected with the pS189 plasmids. Forty-eight hours after transfection, the plasmids were rescued from the cells by the Hirt method (Hirt, 1967) , puri®ed with phenol extraction, and restricted with DpnI to cleave plasmids which had not replicated. The non-digested plasmids were transfected into E. coli MBM7070 by the heat-shock method. Transformed bacteria were plated on LB agar plates containing ampicillin (50 mg/ml), 2 mg of 5-bromo-4-chloro-3-indoyl-b-D-galactosidase (X-Gal), and 12 mg of isopropyl-b-D-thiogalactoside (IPTG). Bacterial colonies containing plasmids with mutant or wild-type suppressor tRNA genes (SupF) were identi®ed by color (cells containing wild-type plasmid are blue and cells with mutant plasmids are light blue or white). The phenotype of each colony was con®rmed by passage to a second plate, and in selected cases the plasmids were recovered and further tested by retransfection to con®rm that they carry a mutation of the supF gene. Mutagenic frequency was determined as percentage of white and light blue colonies to the total colonies. Dierences in the mutation frequency were analysed using the Binomial comparison of two Poisson rates.
To investigate the eect of MNNG on the mutation frequency of pS189 plasmids, the cells were exposed to MNNG (1.0 mg/ml) for 2 h and cultured in fresh medium for 24 additional hours. The plasmids were then rescued and prepared as described above to determine the mutation frequency.
Analysis of mutant pS189 plasmids
To analyse the nature of the mutations, mutant plasmids were isolated from the white and light blue bacterial colonies for PCR ampli®cation of the supF gene. The sequences of the primers were: Sense primer, 5'-GAATTCT-TTCTCAACGTAACA-3'; antisense primer, 5'-TGCGCTCTGCTGAAGCCAG-T-3'. In a total volume of 20 ml, 100 ng of DNA was dissolved in a solution containing 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 0.01% gelatin, 0.2 mM each of the four deoxyribonucleotide triphosphates, and 2.5 unit of RNAase inhibitor. The mixture was incubated at 948C for 45 s, at 558C for 30 s, and at 728C for 1.5 min for 25 cycles. The ampli®ed DNA fragments were electrophoresed in 1.2% agarose gel. When the size of the ampli®ed fragment was greater or smaller than that of the wild-type, the mutation was classi®ed as insertion or deletion, respectively. However, it is possible that either insertion or deletion mutations could contain other type of mutations. To rule out this possibility, the entire supF region of all mutants were sequenced. The ampli®ed mutant fragments whose size was the same as that of the wild-type supF region were sequenced to con®rm and identify the type of point mutations. The nucleotide sequences of the ampli®ed region were determined by the primer extension method from at least ten clones of each cDNA using Sequenase (USB Corp, Cleveland, OH) as described before (Shin et al., 1996) .
